SEC 13F Intelligence

Bayesian Capital Management, LP / ABT

Bayesian Capital Management, LP’s Abbott Laboratories Position

Does Bayesian Capital Management, LP own Abbott Laboratories (ABT)? Not currently — the last reported position was 6.1K shares worth $764,269 in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$764,269
Q4 2025
Shares
6.1K
% of Portfolio
+1.75%
Quarters Held
9
position exited

Position History ABT

Reported value by quarter
Q3 ’20: $2MQ3 ’20Q4 ’20: $405,000Q3 ’21: $2MQ3 ’21Q3 ’22: $290,000Q2 ’23: $4MQ2 ’23Q3 ’23: $542,360Q4 ’23: $6MQ4 ’23Q1 ’24: $2MQ4 ’25: $764,269Q4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20256.1K$764,269+1.75%
Q1 202414.6K$2M+0.16%
Q4 202355.5K$6M+0.65%
Q3 20235.6K$542,360+0.06%
Q2 202333.5K$4M+0.39%
Q3 20223.0K$290,000+0.06%
Q3 202118.6K$2M+0.64%
Q4 20203.7K$405,000+0.11%
Q3 202013.8K$2M+0.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bayesian Capital Management, LP’s full portfolio or all institutional holders of ABT.